President-elect Joe Biden revealed on November 9, 2020, the members of his COVID-19 task force. His swift announcement of the task force clarifies that addressing the health and economic problems related to COVID-19 is his immediate priority. The pres…
My first meeting with a therapist was a success: she specialized in type-A personalities, was transparent about her eclectic approach, and her office – on the bottom floor of a converted San Francisco townhouse – felt somewhere still and safe, a purple…
The FDA said the manufacturer did not provide enough evidence it is safe.
The forecast comes as there are spikes nationwide and the U.S. has soared past 11 million cases.
The CDC issued an emergency declaration in March because of the pandemic.
As Pfizer and Moderna edge closer to regulatory approval, access—and herd immunity—hinges on affordability.
The agency responsible for the transition has refused to start working with the Biden team, and the president has not conceded.
Early data has indicated Pfizer’s vaccine could be up to 90% effective and Moderna’s could be more than 94% effective.
The public health leader stressed the need to continue other methods of disease control, like contact tracing, isolating infected patients and testing.
The U.S. has reported more than a million new cases in less than a week.
